InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
stocktrademan Free
04/12/15 10:44 AM
profile icon
stocktrademan Free
08/19/14 11:18 AM

Cellectis Romainville (CMVLF) RSS Feed

Followers
0
Posters
1
Posts (Today)
0
Posts (Total)
2
Created
08/19/14
Type
Free
Moderators
Cellectis 8 rue de la Croix Jarry Paris, 75013 France - Map Phone: 33 1 81 69 16 00 Website: http://www.cellectis.com Cellectis, together with its subsidiaries, operates as a genome engineering company in France and internationally. The company designs and markets meganucleases and TALENs, which are tools that enable targeted modifications to DNA in the research, biomanufacturing, agro biotechnology, and therapeutic sectors; and develops and markets genome customization products used to create stable and isogenic cell lines with various characteristics and performances for use in the drug development, gene function studies, and protein production sectors. It also develops nucleases for various therapeutic applications, including correction of a genetic defect in the patient’s genome; destruction of viral genomes; or inactivation of genes to create cells with modified characteristics in the fields of cancer, viral infections, and genetic diseases. In addition, the company focuses on plant genome modification using nucleases that recognize specific DNA sequences to develop species with traits of value; and development of stem cell technology for controlling stem cell production and differentiation. It has strategic partnership agreement with Les Laboratoires Servier to develop and commercialize product candidates targeting leukemia and solid tumors. Cellectis was founded in 1999 and is based in Paris, France.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
CMVLF Latest News
  • No Recent News Available for this company!
New Post